Clinical Trial Update: Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the probiotic Lactobacillus FARCIMINIS for diarrhea-predominant irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Lactobacillus FARCIMINIS (Lactobacillus farciminis)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED